Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase

Thomas P. Corner, Anthony Tumber, Eidarus Salah, Mohammadparsa Jabbary, Yu Nakashima, Lara I. Schnaubelt, Shyam Basak, Faisal M. Alshref, Lennart Brewitz*, Christopher J. Schofield*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Derivatives of the Clinically Used HIF Prolyl Hydroxylase Inhibitor Desidustat Are Efficient Inhibitors of Human γ-Butyrobetaine Hydroxylase'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science